Evolus Completes FDA Premarket Approval Submission for Evolysse Dermal Fillers for 'Smile Lines'
Evolus Completes FDA Premarket Approval Submission for Evolysse Dermal Fillers for 'Smile Lines'
Evolus完成了Evolysse皮肤填充剂“微笑纹”FDA预先市场批准申请。
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登录免费看全文
登录/注册